HIV prevention drug backed by RTI International research takes step toward federal regulation
Date Published:
A technology for HIV prevention that’s been studied for years by researchers in the Triangle has taken a big leap…
Life Sciences
Trump visit to highlight Triangle firm’s role in producing possible COVID-19 vaccine
Date Published:
RESEARCH TRIANGLE PARK – North Carolina’s global leadership in biomanufacturing has drawn a major spotlight with a White House announcement…
UNC, Baylor researchers report first successful lymphoma treatment using a cell therapy
Date Published:
CHAPEL HILL – CAR-T cell therapy, which attacks cancer cells using a person’s reprogrammed immune cells, has been used to…
Trump to see the ‘magic’ behind Covid-19 vaccine effort during Morrisville visit
Date Published:
The purpose of President Donald Trump’s upcoming visit to a Triangle biotech is simple: To see where the ‘magic’ happens,…
UNC-Chapel Hill team develops digital tool to fight elder abuse
Date Published:
CHAPEL HILL – UNC-Chapel Hill faculty member Meredith Smith works with North Carolina’s clerks of superior court. In their judicial…
Triangle firm lands deal worth up to $310M for breast cancer treatment
Date Published:
RESEARCH TRIANGLE PARK – G1 Therapeutics has landed a licensing del worth up to $310 million not counting royalties for…
LabCorp partners with JLL to focus on safe return for workforces
Date Published:
In an effort to assist businesses with safely returning employees to the workplace, Burlington-based LabCorp (NYSE: LH) has embarked on…
9 Meters Biopharma, with HQ in Raleigh, begins patient trial for rare GI disease
Date Published:
RALEIGH — 9 Meters Biopharma, a clinical-stage rare gastroenterology company headquartered in Raleigh, has begun dosing the first patients of…
GSK invests hundreds of millions in vaccine firm backed by Bill, Melinda Gates
Date Published:
RESEARCH TRIANGLE PARK – Drug giant GlaxoSmithKline is making a big bet on vaccines created around messenger RNA (mRNA) by…